CDH1 and central nervous system cancer: We found that honokiol inhibited NF-κB expression, while increasing that of E-cadherin, suggesting that honokiol may inhibit migration and invasion of glioma cells in part by inhibition of MMP2/9 expression, as well as attenuation of the NF-κB-mediated E-cadherin pathway.